-
Value of routine ultrasound examination at 35-37 weeks' gestation in diagnosis of fetal abnormalities.
Ficara A, Syngelaki A, Hammami A, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;55:75-80. pdf -
Maternal autoimmune disorders and fetal defects.
Panaitescu AM, Nicolaides K.
J Matern Fetal Neonatal Med 2018;31:1798-1806. pdf -
Impact of holoprosencephaly, exomphalos, megacystis and increased nuchal translucency on first-trimester screening for chromosomal abnormalities.
Syngelaki A, Guerra L, Ceccacci I, Efeturk T, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:45-48. pdf -
A unified approach to risk assessment for fetal aneuploidies.
Wright D, Wright A, Nicolaides KH.
Ultrasound Obstet Gynecol 2015;45:48-54. pdf -
A case-control study of maternal periconceptual and pregnancy recreational drug use and fetal malformation using hair analysis.
David AL, Holloway A, Thomasson L, Syngelaki A, Nicolaides K, Patel RR, Sommerlad B, Wilson A, Martin W, Chitty LS.
PLoS One 2014;9:e111038. pdf -
Digital PCR for noninvasive detection of aneuploidy: power analysis equations for feasibility.
Evans MI, Wright DA, Pergament E, Cuckle HS, Nicolaides KH.
Fetal Diagn Ther 2012;31:244-7. -
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Nicolaides KH.
Prenat Diagn 2011;31:3-6. -
Turning the pyramid of prenatal care.
Nicolaides KH.
Fetal Diagn Ther 2011;29:183-96. -
Nasal bone length in euploid fetuses at 16-24 weeks of gestation by three-dimensional ultrasound.
Persico N, Molina F, Borenstein M, Azumendi G, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;36:285-90. -
The 11-13-week scan: diagnosis and outcome of holoprosencephaly, exomphalos and megacystis.
Kagan KO, Staboulidou I, Syngelaki A, Cruz JJ, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;36:10-4. -
Isolated single umbilical artery: need for specialist fetal echocardiography.
Defigueiredo D, Dagklis T, Zidere V, Allan L, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;36:553-5. -
Isolated single umbilical artery and fetal karyotype.
Dagklis T, Defigueiredo D, Staboulidou I, Casagrandi D, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;36:291-5. -
Aberrant right subclavian artery at 16 to 23 + 6 weeks of gestation: a marker for chromosomal abnormality.
Borenstein M, Minekawa R, Zidere V, Nicolaides K, Allan L.
Ultrasound Obstet Gynecol 2010;36:548-52. -
Maternal serum screening marker levels in women with a previous aneuploidy pregnancy.
Spencer K, Staboulidou I, Cruz JJ, Karagiannis G, Nicolaides KH.
Prenat Diagn 2009;29:1242-3. -
Detection of circulating fetal cells utilizing automated microscopy: potential for noninvasive prenatal diagnosis of chromosomal aneuploidies.
Seppo A, Frisova V, Ichetovkin I, Kim Y, Evans MI, Antsaklis A, Nicolaides KH, Tafas T, Tsipouras P, Kilpatrick MW.
Prenat Diagn 2008;28:815-21. -
Ultrasound findings before amniocentesis in selecting the method of analysing the sample.
Kagan KO, Chitty LS, Cicero S, Eleftheriades M, Nicolaides KH.
Prenat Diagn 2007;27:34-9. -
Metopic suture in fetuses with Apert syndrome at 22-27 weeks of gestation.
Faro C, Chaoui R, Wegrzyn P, Levaillant JM, Benoit B, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:28-33. -
Evaluation of human chorionic gonadotropin beta-subunit mRNA concentrations in maternal serum in aneuploid pregnancies: A feasibility study.
Ng EK, El-Sheikhah A, Chiu RW, Chan KC, Hogg M, Bindra R, Leung TN, Lau TK, Nicolaides KH, Lo YM.
Clin Chem 2004;50:1055-7. -
Assessment of efficacy of cell separation techniques used in the enrichment of foetal erythroblasts from maternal blood: triple density gradient vs single density gradient.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
Clin Lab Haematol 2004;26:123-8. -
Screening for chromosomal defects.
Nicolaides KH.
Ultrasound Obstet Gynecol 2003;21:313-21.